Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Talia M Mota

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
AIDS (London, England)|March 17, 2017
No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapyTalia M Mota, Thomas A Rasmussen, Ajantha Rhodes, et al.
Nature|October 14, 2018
Publisher Correction: Evidence that CD32a does not mark the HIV-1 latent reservoirChrista E Osuna, So-Yon Lim, Jessica L Kublin, et al.
Journal of Virology|February 14, 2020
Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8<sup>+</sup> T Cell Function Reveals Multiple Limitations of Class I-Selective Histone Deacetylase Inhibitors during HIV-1 Latency ReversalTalia M Mota, Chase D McCann, Ali Danesh, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
HIV reservoirs are dominated by genetically younger and clonally enriched provirusesNatalie N Kinloch, Aniqa Shahid, Winnie Dong, et al.
Mbio|November 16, 2023
HIV reservoirs are dominated by genetically younger and clonally enriched provirusesNatalie N Kinloch, Aniqa Shahid, Winnie Dong, et al.
Journal of Virology|May 13, 2021
Selective BCL-X<sub>L</sub> Antagonists Eliminate Infected Cells from a Primary-Cell Model of HIV Latency but Not from <i>Ex Vivo</i> ReservoirsYanqin Ren, Szu Han Huang, Amanda B Macedo, et al.
Retrovirology|July 28, 2016
HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κBSuha Saleh, Hao K Lu, Vanessa Evans, et al.
The Journal of Experimental Medicine|May 14, 2021
A participant-derived xenograft model of HIV enables long-term evaluation of autologous immunotherapiesChase D McCann, Christiaan H van Dorp, Ali Danesh, et al.
The Journal of Clinical Investigation|February 7, 2020
BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivoYanqin Ren, Szu Han Huang, Shabnum Patel, et al.
JCI Insight|January 5, 2021
HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapyEva M Stevenson, Adam R Ward, Ronald Truong, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
AIDS (London, England)|March 17, 2017
No adverse safety or virological changes 2 years following vorinostat in HIV-infected individuals on antiretroviral therapyTalia M Mota, Thomas A Rasmussen, Ajantha Rhodes, et al.
Nature|October 14, 2018
Publisher Correction: Evidence that CD32a does not mark the HIV-1 latent reservoirChrista E Osuna, So-Yon Lim, Jessica L Kublin, et al.
Journal of Virology|February 14, 2020
Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8<sup>+</sup> T Cell Function Reveals Multiple Limitations of Class I-Selective Histone Deacetylase Inhibitors during HIV-1 Latency ReversalTalia M Mota, Chase D McCann, Ali Danesh, et al.
Biorxiv : the Preprint Server for Biology|April 24, 2023
HIV reservoirs are dominated by genetically younger and clonally enriched provirusesNatalie N Kinloch, Aniqa Shahid, Winnie Dong, et al.
Mbio|November 16, 2023
HIV reservoirs are dominated by genetically younger and clonally enriched provirusesNatalie N Kinloch, Aniqa Shahid, Winnie Dong, et al.
Journal of Virology|May 13, 2021
Selective BCL-X<sub>L</sub> Antagonists Eliminate Infected Cells from a Primary-Cell Model of HIV Latency but Not from <i>Ex Vivo</i> ReservoirsYanqin Ren, Szu Han Huang, Amanda B Macedo, et al.
Retrovirology|July 28, 2016
HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κBSuha Saleh, Hao K Lu, Vanessa Evans, et al.
The Journal of Experimental Medicine|May 14, 2021
A participant-derived xenograft model of HIV enables long-term evaluation of autologous immunotherapiesChase D McCann, Christiaan H van Dorp, Ali Danesh, et al.
The Journal of Clinical Investigation|February 7, 2020
BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivoYanqin Ren, Szu Han Huang, Shabnum Patel, et al.
JCI Insight|January 5, 2021
HIV-specific T cell responses reflect substantive in vivo interactions with antigen despite long-term therapyEva M Stevenson, Adam R Ward, Ronald Truong, et al.
Pageof 3